Notice2024-11725
Notice of Award of a Single Source Cooperative Agreement To Fund Universidad del Valle de Guatemala
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 29, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $5,000,000 with an expected total funding of approximately $25,000,000 over a 5-year period, to the Universidad del Valle de Guatemala. This award will build upon previously funded Global Health Security projects, and specifically surveillance activities by CDC to collaboratively work with host countries to create sustainable systems that can inform local public health policy.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 104 (Wednesday, May 29, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 104 (Wednesday, May 29, 2024)]
[Notices]
[Pages 46400-46401]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-11725]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single Source Cooperative Agreement To Fund
Universidad del Valle de Guatemala
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $5,000,000 with an expected total funding of
approximately $25,000,000 over a 5-year period, to the Universidad del
Valle de
[[Page 46401]]
Guatemala. This award will build upon previously funded Global Health
Security projects, and specifically surveillance activities by CDC to
collaboratively work with host countries to create sustainable systems
that can inform local public health policy.
DATES: The period for this award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Shana Eatman, Centers for Disease
Control and Prevention, 1600 Clifton Rd., Atlanta, GA, Telephone: 770-
488-3933, Email: <a href="/cdn-cgi/l/email-protection#387c7f706876777e774b785b5c5b165f574e"><span class="__cf_email__" data-cfemail="2367646b736d6c656c50634047400d444c55">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single source award will build on
existing public health infrastructure and CDC-supported surveillance
and workforce development platform in the region. This award will
enable CDC to work collaboratively with recipients to sustain its
Global Health Security Agenda (GHSA) efforts to strengthen health
protection, detection, and response capacity in Guatemala/Central
America. Universidad del Valle de Guatemala is in a unique position to
conduct this work, as it will focus on multi-pathogen key public health
impact disease surveillance of respiratory pathogen surveillance,
support for entomological activities and public health workforce
development.
Summary of the Award
Recipient: Universidad del Valle de Guatemala.
Purpose of the Award: The purpose of this award is to enhance
global health security in Guatemala/CA through epidemiologic, clinical,
and laboratory-based surveillance. This award should contribute to
strengthening national notifiable disease surveillance and translating
data into public health action.
Amount of Award: $5,000,000 in Federal Fiscal Year (FFY) 2024
funds, with a total estimated $25,000,000 for the 5-year period of
performance, subject to availability of funds. Please note, Year 1
funding is as follows: $5,000,000 for Core Component 1, $10,000,000 for
Approved but Unfunded (ABU) Component 2, $15,000,000 Component 3 (ABU),
and $15,000,000 for (ABU) Component 4.
Period of Performance: September 30, 2024, through September 29,
2029.
Authority: This program is authorized under section 307 of the
Public Health Service Act [42 U.S.C. 242I] and section 317(k)(2) of the
Public Health Service Act [42 U.S.C. 247(b)(k2].
Dated: May 21, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-11725 Filed 5-28-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 29, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.